{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T22:51:34Z","timestamp":1788821494434,"version":"build-2803163510"},"reference-count":50,"publisher":"American Medical Association (AMA)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"\n Importance<\/jats:title>\n Physicians endorse deprescribing of risky or unnecessary medications for older adults (aged \u226565 years) with dementia, but there is a lack of information on what influences decisions to deprescribe in this population.<\/jats:p>\n <\/jats:sec>\n \n Objective<\/jats:title>\n To understand how physicians make decisions to deprescribe for older adults with moderate dementia and ethical and pragmatic concerns influencing those decisions.<\/jats:p>\n <\/jats:sec>\n \n Design, Setting, and Participants<\/jats:title>\n A cross-sectional national mailed survey study of a random sample of 3000 primary care physicians from the American Medical Association Physician Masterfile who care for older adults was conducted from January 15 to December 31, 2021.<\/jats:p>\n <\/jats:sec>\n \n Main Outcomes and Measures<\/jats:title>\n The study randomized participants to consider 2 clinical scenarios in which a physician may decide to deprescribe a medication for older adults with moderate dementia: 1 in which the medication could cause an adverse drug event if continued and the other in which there is no evidence of benefit. Participants ranked 9 factors related to possible ethical and pragmatic concerns through best-worst scaling methods (from greatest barrier to smallest barrier to deprescribing). Conditional logit regression quantified the relative importance for each factor as a barrier to deprescribing.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n A total of 890 physicians (35.0%) returned surveys; 511 (57.4%) were male, and the mean (SD) years since graduation was 26.0 (11.7). Most physicians had a primary specialty in family practice (50.4% [449 of 890]) and internal medicine (43.5% [387 of 890]). A total of 689 surveys were sufficiently complete to analyze. In both clinical scenarios, the 2 greatest barriers to deprescribing were (1) the patient or family reporting symptomatic benefit from the medication (beneficence and autonomy) and (2) the medication having been prescribed by another physician (autonomy and nonmaleficence). The least influential factor was ease of paying for the medication (justice).<\/jats:p>\n <\/jats:sec>\n \n Conclusions and Relevance<\/jats:title>\n Findings from this national survey study of primary care physicians suggests that understanding ethical aspects of physician decision-making can inform clinician education about medication management and deprescribing decisions for older adults with moderate dementia.<\/jats:p>\n <\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2023.36728","type":"journal-article","created":{"date-parts":[[2023,10,3]],"date-time":"2023-10-03T11:05:53Z","timestamp":1696331153000},"page":"e2336728","source":"Crossref","is-referenced-by-count":15,"title":["Ethical Aspects of Physician Decision-Making for Deprescribing Among Older Adults With Dementia"],"prefix":"10.1001","volume":"6","author":[{"given":"Jonathan D.","family":"Norton","sequence":"first","affiliation":[{"name":"Johns Hopkins University School of Medicine, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chan","family":"Zeng","sequence":"additional","affiliation":[{"name":"Institute for Health Research, Kaiser Permanente Colorado, Aurora"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth A.","family":"Bayliss","sequence":"additional","affiliation":[{"name":"Institute for Health Research, Kaiser Permanente Colorado, Aurora"},{"name":"Department of Family Medicine, University of Colorado School of Medicine, Aurora"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan M.","family":"Shetterly","sequence":"additional","affiliation":[{"name":"Institute for Health Research, Kaiser Permanente Colorado, Aurora"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Williams","sequence":"additional","affiliation":[{"name":"Johns Hopkins University School of Medicine, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Reeve","sequence":"additional","affiliation":[{"name":"Centre for Medicine Use and Safety, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University, Melbourne, Victoria, Australia"},{"name":"Quality Use of Medicines and Pharmacy Research Centre, Clinical and Health Sciences, University of South Australia, Adelaide, South Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew K.","family":"Wynia","sequence":"additional","affiliation":[{"name":"University of Colorado Center for Bioethics and Humanities, Anschutz Medical Campus, Aurora"},{"name":"Department of Internal Medicine, University of Colorado School of Medicine, Aurora"},{"name":"Department of Health Policy and Management, Colorado School of Public Health, Aurora"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariel R.","family":"Green","sequence":"additional","affiliation":[{"name":"Johns Hopkins University School of Medicine, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie L.","family":"Drace","sequence":"additional","affiliation":[{"name":"Institute for Health Research, Kaiser Permanente Colorado, Aurora"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathy S.","family":"Gleason","sequence":"additional","affiliation":[{"name":"Institute for Health Research, Kaiser Permanente Colorado, Aurora"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Orla C.","family":"Sheehan","sequence":"additional","affiliation":[{"name":"RCSI Hospitals Group, Connolly Hospital, Dublin, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia M.","family":"Boyd","sequence":"additional","affiliation":[{"name":"Johns Hopkins University School of Medicine, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2023,10,3]]},"reference":[{"issue":"10","key":"zoi231061r1","doi-asserted-by":"publisher","first-page":"2895","DOI":"10.1111\/jgs.v70.10","article-title":"Association between willingness to deprescribe and health outcome priorities among US older adults: results of a national survey.","volume":"70","author":"Green","year":"2022","journal-title":"J Am Geriatr Soc"},{"issue":"4","key":"zoi231061r2","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1111\/bcp.2014.78.issue-4","article-title":"Review of deprescribing processes and development of an evidence-based, patient-centred deprescribing process.","volume":"78","author":"Reeve","year":"2014","journal-title":"Br J Clin Pharmacol"},{"issue":"5","key":"zoi231061r3","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1001\/jamainternmed.2015.0324","article-title":"Reducing inappropriate polypharmacy: the process of deprescribing.","volume":"175","author":"Scott","year":"2015","journal-title":"JAMA Intern Med"},{"issue":"4","key":"zoi231061r4","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1007\/s11673-016-9736-y","article-title":"The ethics of deprescribing in older adults.","volume":"13","author":"Reeve","year":"2016","journal-title":"J Bioeth Inq"},{"issue":"6","key":"zoi231061r5","doi-asserted-by":"publisher","first-page":"453","DOI":"10.2165\/11631760-000000000-00000","article-title":"Adverse drug reactions in older people: detection and prevention.","volume":"29","author":"Petrovic","year":"2012","journal-title":"Drugs Aging"},{"issue":"2","key":"zoi231061r6","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.cger.2010.02.002","article-title":"The assessment of frailty in older adults.","volume":"26","author":"Abellan van Kan","year":"2010","journal-title":"Clin Geriatr Med"},{"issue":"11","key":"zoi231061r7","doi-asserted-by":"publisher","first-page":"3334","DOI":"10.1111\/jgs.v70.11","article-title":"Deprescribing medications: do out-of-pocket costs have a role?","volume":"70","author":"Hung","year":"2022","journal-title":"J Am Geriatr Soc"},{"issue":"4","key":"zoi231061r8","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.3233\/JAD-170842","article-title":"Prevalence of potentially inappropriate medication use in older inpatients with and without cognitive impairment: a systematic review.","volume":"61","author":"Redston","year":"2018","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"zoi231061r9","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1177\/2042098616670798","article-title":"Polypharmacy and inappropriate medication use in patients with dementia: an underresearched problem.","volume":"8","author":"Parsons","year":"2017","journal-title":"Ther Adv Drug Saf"},{"issue":"3","key":"zoi231061r10","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/j.nurt.2007.04.004","article-title":"The physician-patient relationship in dementia care.","volume":"4","author":"Blass","year":"2007","journal-title":"Neurotherapeutics"},{"issue":"4","key":"zoi231061r11","first-page":"277","article-title":"Clinical provider perceptions of proactive medication discontinuation.","volume":"21","author":"Linsky","year":"2015","journal-title":"Am J Manag Care"},{"issue":"4","key":"zoi231061r12","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0151066","article-title":"Challenges and enablers of deprescribing: a general practitioner perspective.","volume":"11","author":"Ailabouni","year":"2016","journal-title":"PLoS One"},{"issue":"8","key":"zoi231061r13","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1177\/1060028016652997","article-title":"Health care practitioners\u2019 perspectives on deprescribing anticholinergic and sedative medications in older adults.","volume":"50","author":"Kouladjian","year":"2016","journal-title":"Ann Pharmacother"},{"issue":"13","key":"zoi231061r14","doi-asserted-by":"publisher","first-page":"1936","DOI":"10.1177\/1049732316687732","article-title":"Negotiating \u201cunmeasurable harm and benefit\u201d: perspectives of general practitioners and consultant pharmacists on deprescribing in the primary care setting.","volume":"27","author":"Anderson","year":"2017","journal-title":"Qual Health Res"},{"issue":"4","key":"zoi231061r15","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1370\/afm.2094","article-title":"Swimming against the tide: primary care physicians\u2019 views on deprescribing in everyday practice.","volume":"15","author":"Wallis","year":"2017","journal-title":"Ann Fam Med"},{"issue":"3","key":"zoi231061r16","doi-asserted-by":"publisher","first-page":"383","DOI":"10.3122\/jabfm.2019.03.180335","article-title":"Clinicians\u2019 perspectives on barriers and enablers of optimal prescribing in patients with dementia and coexisting conditions.","volume":"32","author":"Green","year":"2019","journal-title":"J Am Board Fam Med"},{"key":"zoi231061r17","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.maturitas.2020.01.009","article-title":"Views of medical practitioners about deprescribing in older adults: findings from an Italian qualitative study.","volume":"134","author":"D\u2019Avanzo","year":"2020","journal-title":"Maturitas"},{"issue":"10","key":"zoi231061r18","doi-asserted-by":"publisher","first-page":"3015","DOI":"10.1007\/s11606-020-06493-8","article-title":"Patient and physician perspectives of deprescribing potentially inappropriate medications in older adults with a history of falls: a qualitative study.","volume":"36","author":"Hahn","year":"2021","journal-title":"J Gen Intern Med"},{"issue":"3","key":"zoi231061r19","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/s40266-021-00918-7","article-title":"Barriers and enablers of healthcare providers to deprescribe cardiometabolic medication in older patients: a focus group study.","volume":"39","author":"Abou","year":"2022","journal-title":"Drugs Aging"},{"issue":"1","key":"zoi231061r20","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s11096-021-01336-w","article-title":"Physicians\u2019 perceived barriers and enablers for deprescribing among older patients at public primary care clinics: a qualitative study.","volume":"44","author":"Tangiisuran","year":"2022","journal-title":"Int J Clin Pharm"},{"issue":"2","key":"zoi231061r21","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1200\/JCO.18.00589","article-title":"Conceptualizing de-implementation in cancer care delivery.","volume":"37","author":"Norton","year":"2019","journal-title":"J Clin Oncol"},{"issue":"1","key":"zoi231061r22","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1111\/jrh.v38.1","article-title":"Food acquisition practices, body mass index, and dietary outcomes by level of rurality.","volume":"38","author":"Kegler","year":"2022","journal-title":"J Rural Health"},{"issue":"4","key":"zoi231061r23","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1111\/jrh.v37.4","article-title":"Distribution of physician specialties by rurality.","volume":"37","author":"Barreto","year":"2021","journal-title":"J Rural Health"},{"issue":"4","key":"zoi231061r24","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1136\/jme.2002.000729","article-title":"Gaps, conflicts, and consensus in the ethics statements of professional associations, medical groups, and health plans.","volume":"30","author":"Berkman","year":"2004","journal-title":"J Med Ethics"},{"issue":"4","key":"zoi231061r25","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.2633","article-title":"Assessment of patient-preferred language to achieve goal-aligned deprescribing in older adults.","volume":"4","author":"Green","year":"2021","journal-title":"JAMA Netw Open"},{"issue":"12","key":"zoi231061r26","doi-asserted-by":"publisher","first-page":"3556","DOI":"10.1007\/s11606-020-06063-y","article-title":"Designing a primary care-based deprescribing intervention for patients with dementia and multiple chronic conditions: a qualitative study.","volume":"35","author":"Green","year":"2020","journal-title":"J Gen Intern Med"},{"issue":"1","key":"zoi231061r27","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.jhealeco.2006.04.002","article-title":"Best\u2013worst scaling: what it can do for health care research and how to do it.","volume":"26","author":"Flynn","year":"2007","journal-title":"J Health Econ"},{"issue":"1","key":"zoi231061r29","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1186\/s12955-019-1250-6","article-title":"Outcome preferences of older people with multiple chronic conditions and hypertension: a cross-sectional survey using best-worst scaling.","volume":"17","author":"Aschmann","year":"2019","journal-title":"Health Qual Life Outcomes"},{"issue":"1","key":"zoi231061r30","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s13561-015-0079-x","article-title":"Experimental measurement of preferences in health and healthcare using best-worst scaling: an overview.","volume":"6","author":"M\u00fchlbacher","year":"2016","journal-title":"Health Econ Rev"},{"issue":"2","key":"zoi231061r32","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap)\u2013a metadata-driven methodology and workflow process for providing translational research informatics support.","volume":"42","author":"Harris","year":"2009","journal-title":"J Biomed Inform"},{"issue":"1","key":"zoi231061r33","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1111\/jgs.v68.1","article-title":"Physician perspectives on deprescribing cardiovascular medications for older adults.","volume":"68","author":"Goyal","year":"2020","journal-title":"J Am Geriatr Soc"},{"issue":"9","key":"zoi231061r34","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1007\/s40266-022-00967-6","article-title":"Primary-care prescribers\u2019 perspectives on deprescribing opioids and benzodiazepines in older adults.","volume":"39","author":"Niznik","year":"2022","journal-title":"Drugs Aging"},{"issue":"5","key":"zoi231061r35","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1093\/gerona\/glab222","article-title":"Consumer attitudes towards deprescribing: a systematic review and meta-analysis.","volume":"77","author":"Weir","year":"2022","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"1","key":"zoi231061r36","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1136\/ejhpharm-2016-000921","article-title":"Challenges of deprescribing in the multimorbid patient.","volume":"24","author":"Cullinan","year":"2017","journal-title":"Eur J Hosp Pharm"},{"issue":"1","key":"zoi231061r37","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s13012-019-0960-9","article-title":"Unpacking the complexities of de-implementing inappropriate health interventions.","volume":"15","author":"Norton","year":"2020","journal-title":"Implement Sci"},{"issue":"7","key":"zoi231061r38","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1016\/j.jamda.2021.05.012","article-title":"Chronic care, dementia care management, and financial considerations.","volume":"22","author":"Coe","year":"2021","journal-title":"J Am Med Dir Assoc"},{"issue":"1","key":"zoi231061r39","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1111\/hesr.2018.53.issue-1","article-title":"Health services utilization in older adults with dementia receiving care coordination: the MIND at Home Trial.","volume":"53","author":"Amjad","year":"2018","journal-title":"Health Serv Res"},{"key":"zoi231061r40","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.cct.2018.05.009","article-title":"MIND at Home-Streamlined: study protocol for a randomized trial of home-based care coordination for persons with dementia and their caregivers.","volume":"71","author":"Samus","year":"2018","journal-title":"Contemp Clin Trials"},{"issue":"9","key":"zoi231061r41","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1377\/hlthaff.2016.0140","article-title":"Home-based care program reduces disability and promotes aging in place.","volume":"35","author":"Szanton","year":"2016","journal-title":"Health Aff (Millwood)"},{"key":"zoi231061r42","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.maturitas.2019.12.010","article-title":"Non-pharmacological, non-surgical interventions for urinary incontinence in older persons: a systematic review of systematic reviews. The SENATOR project ONTOP series.","volume":"133","author":"Kilpatrick","year":"2020","journal-title":"Maturitas"},{"issue":"10","key":"zoi231061r43","doi-asserted-by":"publisher","first-page":"2009","DOI":"10.1111\/jgs.2018.66.issue-10","article-title":"Feasibility of implementing patient priorities care for older adults with multiple chronic conditions.","volume":"66","author":"Blaum","year":"2018","journal-title":"J Am Geriatr Soc"},{"issue":"5","key":"zoi231061r46","first-page":"354","article-title":"Deprescribing proton pump inhibitors: evidence-based clinical practice guideline.","volume":"63","author":"Farrell","year":"2017","journal-title":"Can Fam Physician"},{"issue":"11","key":"zoi231061r47","first-page":"832","article-title":"Deprescribing antihyperglycemic agents in older persons: evidence-based clinical practice guideline.","volume":"63","author":"Farrell","year":"2017","journal-title":"Can Fam Physician"},{"issue":"1","key":"zoi231061r48","first-page":"17","article-title":"Deprescribing antipsychotics for behavioural and psychological symptoms of dementia and insomnia: evidence-based clinical practice guideline.","volume":"64","author":"Bjerre","year":"2018","journal-title":"Can Fam Physician"},{"issue":"5","key":"zoi231061r49","first-page":"339","article-title":"Deprescribing benzodiazepine receptor agonists: evidence-based clinical practice guideline.","volume":"64","author":"Pottie","year":"2018","journal-title":"Can Fam Physician"},{"key":"zoi231061r50","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2021.108811","article-title":"Primary care physicians\u2019 preparedness to treat opioid use disorder in the United States: a cross-sectional survey.","volume":"225","author":"Foti","year":"2021","journal-title":"Drug Alcohol Depend"},{"key":"zoi231061r28","doi-asserted-by":"crossref","DOI":"10.1017\/CBO9781107337855","volume-title":"Best-Worst Scaling: Theory, Methods and Applications","author":"Louviere","year":"2015"},{"key":"zoi231061r31","doi-asserted-by":"crossref","DOI":"10.1002\/9781394260645","volume-title":"Internet, Phone, Mail, and Mixed-Mode Surveys: The Tailored Design Method","author":"Dillman","year":"2014"},{"key":"zoi231061r44","unstructured":"Bruy\u00e8re Research Institute. Deprescribing Guidelines and Algorithms. Accessed August 3, 2023. https:\/\/deprescribing.org\/resources\/deprescribing-guidelines-algorithms\/"},{"key":"zoi231061r45","unstructured":"Reeve? E, Farrell? B, Thompson? W, . Evidence-based clinical practice guideline for deprescribing cholinesterase inhibitors and memantine: recommendations. February 2018. Accessed August 29, 2023. http:\/\/sydney.edu.au\/medicine\/cdpc\/resources\/deprescribing-guidelines.php"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2809989\/norton_2023_oi_231061_1695316362.14196.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,29]],"date-time":"2024-10-29T19:00:34Z","timestamp":1730228434000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2809989"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,3]]},"references-count":50,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2023,10,2]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2023.36728","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,3]]}}}